Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether PRX302 is safe and effective in the
treatment of moderate to severe Benign Prostatic Hyperplasia (BPH).